Skip to main content
Log in

Fate of fluazifop butyl in rat and human skin in vitro

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Enzyme mediated hydrolysis of fluazifop butyl has been measured with rat and human skin post-mitochondrial fractions. Rat skin had a ten times greater capacity to metabolise fluazifop butyl than human skin, but the enzyme affinities were similar. The post-mitochondrial fraction metabolism was compared to that seen during absorption in a flow through diffusion cell with viable skin. Limited hydrolysis of absorbed fluazifop butyl was seen in rat skin, but increased two fold if the stratum corneum was removed. The stratum corneum was found to retain fluazifop butyl. When the skin was pre-incubated with the esterase inhibitor bis (p-nitrophenol) phosphate (BNPP), reduced metabolism was seen. No metabolism of fluazifop butyl was seen in human skin during absorption. Retention of the compound by the stratum corneum is postulated to restrict the accessibility of the compound to the enzyme site, thus influencing the observed metabolism during the absorption process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bronaugh RL, Stewart RF (1985) Methods for in vitro percutaneous absorption studies IV: the flow through diffusion cell. J Pharm Sci 74: 64–67

    PubMed  Google Scholar 

  • Carver MP, Williams PL, Riviere JE (1989) The isolated perfused porcine skin flap III. Percutaneous absorption pharmacokinetics of organophosphates, steroids benzoic acid and caffeine. Toxicol Appl Pharmacol 97: 324–337

    PubMed  Google Scholar 

  • Clark NWE, Blain PG, Scott RC, Williams FM (1991) Viability of skin absorption systems. In: Guy RH, Hadgraft J, Scott RC, Bodde HE (eds) Prediction of percutaneous penetration, vol 2. IBC Technical Services, London, pp 544–547

    Google Scholar 

  • Franz TJ (1978) The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. Curr Probl Dermatol 7: 58–68

    PubMed  Google Scholar 

  • Jernstrom B, Dock L, Hall M, Mannervik B, Tahir MK, Grover PL (1989) Glutathione transferase catalysed conjugation of benzo [a] pyrene 7,8-diol 9,10-epoxide with glutathione in human skin. Chem Biol Interact 70: 173–180

    PubMed  Google Scholar 

  • Kao J, Carver MP (1990) Cutaneous metabolism of xenobiotics. Drug Metab Rev 22: 363–410

    PubMed  Google Scholar 

  • Kao J, Hall J (1987) Skin absorption and cutaneous first pass metabolism of topical steroids: in vitro studies with mouse skin in organ culture. J Pharmacol Exp Ther 241: 482–487

    PubMed  Google Scholar 

  • Kao J, Patterson FK, Hall J (1985) Skin penetration and metabolism of topically applied chemicals in six mammalian species: benzo (a) pyrene and testosterone. Toxicol Appl Pharmacol 81: 502–516

    PubMed  Google Scholar 

  • Macpherson SE, Scott RC, Williams FM (1991 a) Percutaneous absorption and metabolism of aldrin by rat skin in diffusion cells. Arch Toxicol 65: 599–602

    PubMed  Google Scholar 

  • Macpherson SE, Scott RC, Williams FM (1991 b) Fate of carbaryl in rat skin. Arch Toxicol 65: 594–598

    PubMed  Google Scholar 

  • Moody RP, Ritter L (1992) An automated in vitro dermal absorption procedure: II Comparative in vivo and in vitro dermal absorption of the herbicide fenoxaprop-ethyl (HOE 33 171) in rats. Toxicol In Vitro 6: 53–59

    Google Scholar 

  • McCracken N, Blain PG, Williams FM (1993) Nature and role of xenobiotic metabolising esterases in rat lung, liver and skin. Biochem Pharmacol (in press)

  • Pinkus H (1951) Examination of the epidermis by the strip method of removing horny layers. J Invest Dermatol 16: 383–386

    PubMed  Google Scholar 

  • Potts RO, McNeill SC, Desbonnet CR, Wakshull E (1989) Transdermal drug transport and metabolism II: the role of competing kinetic events. Pharm Res 6: 119–124

    PubMed  Google Scholar 

  • Ramsey JD, Woollen BH, Auton TR, Batten PL, Leeser JE (1990) Percutaneous absorption of the lipophilic herbicide fluazifop butyl in man. In: Scott RC, Guy RH, Hadgraft J (eds) Prediction of percutaneous penetration. IBC Technical Services, London, pp 49–57

    Google Scholar 

  • Rettie AE (1983) Mixed function oxidase in mammalian skin. PhD thesis, University of Newcastle-upon-Tyne, UK

    Google Scholar 

  • Scott RC, Dugard PH (1989) The properties of skin as a diffusion barrier and route of absorption. In: Greaves MW, Shuster S (eds) Pharmacology of the skin II. Springer Verlag, Berlin, pp 93–114

    Google Scholar 

  • Scott RC, Corrigan MA, Smith F, Mason H (1991) The influence of skin structure on permeability: an intersite and interspecies comparison with hydrophilic penetrants. J Invest Dermatol 96: 921–925

    PubMed  Google Scholar 

  • Storm JE, Collier SW, Stewart RF, Bronaugh RL (1990) Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity. Fundam Appl Toxicol 15: 132–141

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clark, N.W.E., Scott, R.C., Blain, P.G. et al. Fate of fluazifop butyl in rat and human skin in vitro. Arch Toxicol 67, 44–48 (1993). https://doi.org/10.1007/BF02072034

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02072034

Key words

Navigation